BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14668532)

  • 1. TOR signaling.
    Harris TE; Lawrence JC
    Sci STKE; 2003 Dec; 2003(212):re15. PubMed ID: 14668532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase.
    Avruch J; Hara K; Lin Y; Liu M; Long X; Ortiz-Vega S; Yonezawa K
    Oncogene; 2006 Oct; 25(48):6361-72. PubMed ID: 17041622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.
    Nobukini T; Thomas G
    Novartis Found Symp; 2004; 262():148-54; discussion 154-9, 265-8. PubMed ID: 15562827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.
    Kwiatkowski DJ; Manning BD
    Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R251-8. PubMed ID: 16244323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheb binds and regulates the mTOR kinase.
    Long X; Lin Y; Ortiz-Vega S; Yonezawa K; Avruch J
    Curr Biol; 2005 Apr; 15(8):702-13. PubMed ID: 15854902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth.
    Yang X; Yang C; Farberman A; Rideout TC; de Lange CF; France J; Fan MZ
    J Anim Sci; 2008 Apr; 86(14 Suppl):E36-50. PubMed ID: 17998426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheb activation of mTOR and S6K1 signaling.
    Hanrahan J; Blenis J
    Methods Enzymol; 2006; 407():542-55. PubMed ID: 16757352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1.
    Tee AR; Blenis J; Proud CG
    FEBS Lett; 2005 Aug; 579(21):4763-8. PubMed ID: 16098514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amino acid sensitive TOR pathway from yeast to mammals.
    Dann SG; Thomas G
    FEBS Lett; 2006 May; 580(12):2821-9. PubMed ID: 16684541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mTOR in the management of solid tumors: an overview.
    Strimpakos AS; Karapanagiotou EM; Saif MW; Syrigos KN
    Cancer Treat Rev; 2009 Apr; 35(2):148-59. PubMed ID: 19013721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of microtubule-dependent protein transport by the TSC2/mammalian target of rapamycin pathway.
    Jiang X; Yeung RS
    Cancer Res; 2006 May; 66(10):5258-69. PubMed ID: 16707451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-1 (IGF-1) and leucine activate pig myogenic satellite cells through mammalian target of rapamycin (mTOR) pathway.
    Han B; Tong J; Zhu MJ; Ma C; Du M
    Mol Reprod Dev; 2008 May; 75(5):810-7. PubMed ID: 18033679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSC1-2 tumour suppressor and regulation of mTOR signalling: linking cell growth and proliferation?
    Findlay GM; Harrington LS; Lamb RF
    Curr Opin Genet Dev; 2005 Feb; 15(1):69-76. PubMed ID: 15661536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mammalian target of rapamycin pathway and its role in molecular nutrition regulation.
    Lian J; Yan XH; Peng J; Jiang SW
    Mol Nutr Food Res; 2008 Apr; 52(4):393-9. PubMed ID: 18306429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
    Follo MY; Mongiorgi S; Bosi C; Cappellini A; Finelli C; Chiarini F; Papa V; Libra M; Martinelli G; Cocco L; Martelli AM
    Cancer Res; 2007 May; 67(9):4287-94. PubMed ID: 17483341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR signaling and the molecular adaptation to resistance exercise.
    Bodine SC
    Med Sci Sports Exerc; 2006 Nov; 38(11):1950-7. PubMed ID: 17095929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mTOR pathway and its role in human genetic diseases.
    Rosner M; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
    Mutat Res; 2008; 659(3):284-92. PubMed ID: 18598780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions.
    Kaper F; Dornhoefer N; Giaccia AJ
    Cancer Res; 2006 Feb; 66(3):1561-9. PubMed ID: 16452213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells.
    Edinger AL; Linardic CM; Chiang GG; Thompson CB; Abraham RT
    Cancer Res; 2003 Dec; 63(23):8451-60. PubMed ID: 14679009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding mTOR signaling.
    Yang Q; Guan KL
    Cell Res; 2007 Aug; 17(8):666-81. PubMed ID: 17680028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.